Dexokyt 60mg Capsules (14s)

Description

Dexokyt 60 mg is a delayed-release capsule containing dexlansoprazole, a proton-pump inhibitor that reduces stomach-acid production. It is used for acid-related gastrointestinal conditions, including gastroesophageal reflux disease and healing of erosive esophagitis.

• Manufacturer Name: High Q
• Drug Class: Proton-pump inhibitor
• Dosage Form: Dual Delayed-Release Capsule
• Storage: Store at controlled room temperature, preferably 20–25°C, in the original packaging. Protect from excessive heat, moisture, and light. Keep out of reach of children.
• Pack Size: Pack of 14 Capsules

Dexokyt 60mg Capsules (14s) Available Online in Pakistan

Dwatson offers Dexokyt 60mg Capsules (14s) at Rs.696, with fast, discreet delivery across Pakistan.

Ingredients

• Dexlansoprazole 60 mg

Benefits

• Healing of erosive esophagitis
• Maintenance of healed erosive esophagitis and relief of heartburn
• Short-term treatment of symptomatic non-erosive gastroesophageal reflux disease
• Relief of acid reflux and heartburn symptoms when prescribed by a healthcare professional

Usage & Safety

For Adult

• For healing of erosive esophagitis: 60 mg once daily for up to 8 weeks, or as directed by a physician.
• For maintenance after healing: usually 30 mg once daily; a higher dose may be prescribed for selected patients.
• For symptomatic non-erosive gastroesophageal reflux disease: usually 30 mg once daily for 4 weeks.
• Swallow the capsule whole; do not crush or chew. It may generally be taken with or without food.
• Use the 60 mg strength only according to the prescribed treatment plan.

For Children

• Use in adolescents 12 years and older should follow a physician’s prescription and the indication-specific dose.
• For patients 12 years and older with erosive esophagitis, 60 mg once daily may be prescribed for up to 8 weeks.
• For patients 12 years and older with symptomatic non-erosive gastroesophageal reflux disease, 30 mg once daily is generally used for up to 4 weeks.
• Safety and dosing are not established for children younger than 12 years for this product; use only under specialist supervision.

Side Effects

• Common effects may include headache, abdominal pain, diarrhea, nausea, vomiting, flatulence, and constipation.
• Longer-term use may be associated with low magnesium, vitamin B12 deficiency, bone fractures, intestinal infections, or fundic gland polyps.
• Rare but serious effects include severe or persistent diarrhea, allergic reaction, kidney inflammation, severe skin reactions, irregular heartbeat related to low magnesium, and lupus-like reactions.
• Stop the medicine and seek urgent medical care for facial or throat swelling, breathing difficulty, blistering rash, severe watery diarrhea, or markedly reduced urine output.

Contraindications

• Do not use in patients with a known allergy to dexlansoprazole, other proton-pump inhibitors, or any capsule ingredient.
• Do not use with rilpivirine-containing medicines.
• Seek medical evaluation for unexplained weight loss, difficulty or pain when swallowing, vomiting blood, black stools, persistent vomiting, anemia, or recurrent symptoms.
• Long-term or high-dose use requires medical supervision, particularly in patients with osteoporosis, low magnesium, vitamin B12 deficiency, liver disease, or a history of gastrointestinal infection.

Precautions & Warnings

• Do not combine with rilpivirine-containing products.
• Use caution with medicines whose absorption depends on stomach acidity, including some antifungals, atazanavir, nelfinavir, and certain iron preparations.
• High-dose methotrexate may require temporary discontinuation of proton-pump inhibitor therapy under specialist supervision.
• Monitor when used with warfarin, digoxin, tacrolimus, clopidogrel, or medicines that can lower magnesium.
• Tell the healthcare professional about all prescription medicines, over-the-counter products, and supplements before starting treatment.
• It may generally be taken with or without food, but alcohol and individual trigger foods may worsen reflux symptoms.

Pregnancy

• Use during pregnancy only when clearly needed and recommended by a healthcare professional.
• Available human data for proton-pump inhibitors have not shown a clear increase in major congenital malformations, but specific pregnancy data for dexlansoprazole are limited.
• Discuss treatment choice, dose, and duration with a physician during pregnancy.
• Breastfeeding data for dexlansoprazole are limited; consult a healthcare professional before use while breastfeeding.